Portal Hypertension Not Yet Recruiting Phase 4 Trials for Rifaximin (DB01220)

Also known as: Hypertension Portal / Hypertension, Portal / Portal hypertensions

IndicationStatusPhase
DBCOND0029015 (Portal Hypertension)Not Yet Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs